Jane Spetzler

Title: Jane Spetzler: Innovator in Peptide Therapeutics

Introduction

Jane Spetzler is a notable inventor based in Copenhagen, Denmark. She has made significant contributions to the field of peptide therapeutics, particularly in the development of insulin and IGF-1 receptor agonists and antagonists. Her work focuses on peptide sequences capable of binding to insulin and insulin-like growth factor receptors, which can have important therapeutic applications.

Latest Patents

Jane Spetzler holds 1 patent for her invention titled "Insulin and IGF-1 receptor agonists and antagonists." This patent discloses peptide sequences that can bind to insulin and/or insulin-like growth factor receptors with either agonist or antagonist activity. The invention identifies at least two different binding sites present on these receptors, which selectively bind the peptides. As agonists, certain peptides may be useful for developing therapeutics to supplement or replace endogenous peptide hormones. Additionally, the antagonists may also be developed as therapeutics.

Career Highlights

Throughout her career, Jane has focused on advancing the understanding of peptide interactions with insulin and IGF-1 receptors. Her innovative approach has the potential to lead to new treatments for various metabolic disorders.

Collaborations

Jane has collaborated with talented individuals such as Renuka Pillutla and Renee Brissette, contributing to the advancement of research in her field.

Conclusion

Jane Spetzler's work in peptide therapeutics represents a significant advancement in the development of treatments for metabolic disorders. Her innovative inventions and collaborations continue to pave the way for future research and therapeutic applications.